VIKING GLOBAL INVESTORS LP
CIK 1103804 · last filed 2024-02-28
VIKING GLOBAL INVESTORS LP is a corporate insider who has filed 13 SEC Form 4 insider transactions across 7 companies since 2019. The most recent filing, for BBIO, was dated Jan 31, 2025. Across all open-market trades the lifetime net is −$529.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.86B across reported positions. The firm reports its address in Stamford, CT. 93 SEC filings were submitted jointly with OLE ANDREAS HALVORSEN.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.86B
7
13
-$529.26M
Filer Profile
FLOOR 11
STAMFORD, CT 06901
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RayzeBio, Inc. (RYZB) Delisted | 10%+ Owner | 1,285,223 | $62.49 | $80.31M | $200.00M | 1 | 2023-09-21 |
| Frazier Lifesciences Acquisition Corp (FLACW) Delisted | 10%+ Owner | 1,211,582 | $0.80 | $969.3K | $68.31M | 1 | 2022-11-04 |
| FIGS | 10%+ Owner | 14,785,102 | $13.35 | $197.38M | -$65.49M | 1 | 2021-09-03 |
| RLYB | 10%+ Owner | 524,347 | $16.88 | $8.85M | $73.35M | 1 | 2021-08-02 |
| ADPT | 10%+ Owner | 29,993,708 | $24.20 | $725.85M | -$1.37B | 2 | 2020-12-16 |
| BBIO | 10%+ Owner | 26,620,991 | $72.44 | $1.93B | $560.00M | 1 | 2019-06-28 |
| Urovant Sciences Ltd. (UROV) Delisted | 10%+ Owner | 22,791,378 | $16.24 | $370.13M | $1.93M | 2 | 2019-06-06 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-01-31 | BBIO | Notice (144) | −3,065,616 | -$106.99M | EDGAR |
| 2024-02-28 | — | Other (J) | −53,141,600 | $0 | |
| 2024-01-02 | APG | Notice (144) | −6,500,000 | -$213.72M | EDGAR |
| 2023-09-21 | RayzeBio, Inc. (RYZB) Delisted | Mixed | +53,141,600 | $200.00M | EDGAR |
| 2022-11-04 | Frazier Lifesciences Acquisition Corp (FLACW) Delisted | Buy (P) | +6,776,496 | $68.31M | EDGAR |
| 2021-09-03 | FIGS | Sell (S) | −1,400,000 | -$65.49M | EDGAR |
| 2021-08-02 | RLYB | Mixed | +29,363,439 | $73.35M | EDGAR |
| 2020-12-16 | ADPT | Sell (S) | −9,000,000 | -$500.85M | EDGAR |
| 2020-11-13 | ADPT | Sell (S) | −17,500,000 | -$866.51M | EDGAR |
| 2019-06-28 | BBIO | Mixed | +186,346,937 | $560.00M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.